Effect of stereotactic body radiotherapy dose escalation plus pembrolizumab and trametinib versus stereotactic body radiotherapy dose escalation plus gemcitabine for locally recurrent pancreatic cancer after surgical resection on survival outcomes: A secondary analysis of an open-label, randomised, controlled, phase 2 trialECLINICALMEDICINEIF102023-01-017OAAI
Short-Term Outcomes and Clinical Efficacy of Stereotactic Body Radiation Therapy (SBRT) for Oligometastases of Prostate Cancer in China中国前列腺癌寡转移立体定向放射治疗 (SBRT) 的近期疗效和临床疗效FRONTIERS IN ONCOLOGYIF3.32022-04-281OAAI
Re-Irradiation With Stereotactic Body Radiotherapy for In-Field Recurrence of Pancreatic Cancer After Prior Stereotactic Body Radiotherapy: Analysis of 24 Consecutive CasesFRONTIERS IN ONCOLOGYIF3.32021-11-023OAAI
Stereotactic body radiation therapy with sequential S-1 for patients with locally advanced pancreatic cancer and poor performance status: An open-label, single-arm, phase 2 trialRADIOTHERAPY AND ONCOLOGYIF5.32021-09-017PRE
Development and Validation of Multicenter Predictive Nomograms for Locally Advanced Pancreatic Cancer After ChemoradiotherapyFRONTIERS IN ONCOLOGYIF3.32021-06-084OAAI
Failure patterns and outcomes of dose escalation of stereotactic body radiotherapy for locally advanced pancreatic cancer: a multicenter cohort studyTHERAPEUTIC ADVANCES IN MEDICAL ONCOLOGYIF4.22020-12-1416OAAI
Clinical efficacy of Stereotactic Body Radiation Therapy (SBRT) for adrenal gland metastases: A multi-center retrospective study from ChinaSCIENTIFIC REPORTSIF3.92020-05-1217OAAI
Validation of the eighth edition of the AJCC staging system for patients with pancreatic adenocarcinoma initially receiving chemoradiotherapy and proposal of modificationsCANCER BIOLOGY & MEDICINEIF8.42020-01-011OAAI
Stereotactic Radiation Therapy (SRT) for Brain Metastases of Multiple Primary Tumors: A Single Institution Retrospective AnalysisFRONTIERS IN ONCOLOGYIF3.32019-12-108OAAI
Patterns of Local Failure After Stereotactic Body Radiation Therapy and Sequential Chemotherapy as Initial Treatment for Pancreatic Cancer: Implications of Target Volume DesignINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSIF6.52019-05-0162PREAI
Prediction of overall survival after re-irradiation with stereotactic body radiation therapy for pancreatic cancer with a novel prognostic model (the SCAD score)RADIOTHERAPY AND ONCOLOGYIF5.32018-11-0116PREAI
Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancerRADIATION ONCOLOGYIF3.22018-10-2221OAAI
Optimization of dose distributions of target volumes and organs at risk during stereotactic body radiation therapy for pancreatic cancer with dose-limiting auto-shellsRADIATION ONCOLOGYIF3.22018-01-2210OAAI
Phosphorothioate-modified antisense oligonucleotides against human telomerase reverse transcriptase sensitize cancer cells to radiotherapyMOLECULAR MEDICINE REPORTSIF3.52017-06-149OAAI